Opus Genetics, Inc.
Opus Genetics, Inc. (IRD) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · IRD · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
12
12 Months
Buy/Sell ratio
0.17
Buy/Sell (by trades)
Overall sentiment
Opus Genetics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
IRD insider buying and selling by quarter
IRD insider selling · IRD insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · IRD ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
IRD executive sell shares · IRD board member insider trading · IRD insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund Director | Sale | 1,700,000 | $7.39M⚡ | Form 4 |
| Apr 23, 2026 | YERXA BENJAMIN R President · Director | Sale | 7,470 | $39K | Form 4 |
| Apr 23, 2026 | SCHACHLE JOSEPH K COO | Sale | 4,697 | $25K | Form 4 |
| Apr 23, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | 1,641 | $9K | Form 4 |
| Apr 23, 2026 | Magrath George CEO · Director | Sale | 9,511 | $50K | Form 4 |
| Apr 23, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | 7,542 | $39K | Form 4 |
| Apr 23, 2026 | Gagnon Robert E. CFO | Sale | 7,842 | $41K | Form 4 |
| Apr 20, 2026 | Rodgers Richard J Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | MANUSO JAMES S J Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Graves Adrienne L Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Gallagher Cam Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Benton Susan Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Bennett Jean Director | Award | 24,367 | — | Form 4 |
| Apr 20, 2026 | Ainsworth Sean Director | Award | 24,367 | — | Form 4 |
| Mar 16, 2026 | SCHACHLE JOSEPH K COO | Sale | 3,719 | $20K | Form 4 |
| Mar 16, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | 2,816 | $15K | Form 4 |
| Mar 16, 2026 | Magrath George CEO · Director | Sale | 24,438 | $127K | Form 4 |
| Mar 16, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | 3,719 | $19K | Form 4 |
| Feb 12, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Other | 5,313 | $18K | Form 4 |
| Jan 22, 2026 | YERXA BENJAMIN R President · Director | Award | 400,000 | — | Form 4 |
| Jan 22, 2026 | SCHACHLE JOSEPH K COO | Award | 250,000 | — | Form 4 |
| Jan 22, 2026 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Award | 86,500 | — | Form 4 |
| Jan 22, 2026 | Magrath George CEO · Director | Award | 483,639 | — | Form 4 |
| Jan 22, 2026 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Award | 400,000 | — | Form 4 |
| Jan 22, 2026 | Gagnon Robert E. CFO | Award | 400,000 | — | Form 4 |
Foundation Fighting Blindness Retinal Degeneration Fund
Director
Date
May 18
Shares
1,700,000
Price
$4.35
Value
$7.39M ⚡
YERXA BENJAMIN R
President · Director
Date
Apr 23
Shares
7,470
Price
$5.24
Value
$39K
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Date
Apr 23
Shares
1,641
Price
$5.20
Value
$9K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Date
Apr 23
Shares
7,542
Price
$5.19
Value
$39K
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Date
Mar 16
Shares
2,816
Price
$5.25
Value
$15K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Date
Mar 16
Shares
3,719
Price
$5.12
Value
$19K
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Date
Feb 12
Shares
5,313
Price
$3.39
Value
$18K
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Date
Jan 22
Shares
86,500
Price
—
Value
—
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Date
Jan 22
Shares
400,000
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About IRD insider trading
IRD insider trades
Opus Genetics, Inc. (IRD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Gallagher Cam (Director), Zaremba Rabourn Amy (Head of Fin. Quality Assurance), Magrath George (CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. IRD insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Opus Genetics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
IRD insider trading · 5 questionsThe insiders of Opus Genetics, Inc. (IRD) include executives and directors such as Gallagher Cam (Director), Zaremba Rabourn Amy (Head of Fin. Quality Assurance), Magrath George (CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026